These outcomes, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 help the concept of focusing on ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders. We independently study, overview, and https://georgez184fcz4.ja-blog.com/profile